Champaign, Illinois – Verdant Partners LLC is pleased to announce that Dr. Jan Pen, General Manager of JP Bioconsult based in Leiden, The Netherlands, has joined Verdant as an Advisor effective immediately. Dr. Pen has a background in chemistry and biochemistry, strengthened by executive management and business transaction experience gained over the course of his career, which spans more than 25 years in agricultural, industrial and pharmaceutical life sciences and includes working for start-up, medium-sized and multinational companies.
During his career as an independent consultant, Dr. Pen has provided clients with a broad range of commercial and business services in life sciences including business and strategy development, due diligence, commercial assessment of technologies, and interim CEO of start-up companies. Dr. Pen has worked on numerous assignments across Europe and in other parts of the world.
“Jan’s diverse background and broad skill set will be particularly complimentary to Verdant’s transaction advisory services,” said Garrett Stoerger, Partner at Verdant Partners. “In his consultancy role, Jan’s doctorate degree in biochemistry facilitates a full comprehension of his client’s underlying technology, which is imperative in the ever-changing era of modern agriculture. As a firm that operates exclusively in crop agriculture, this level of technical understanding is one of Verdant’s competitive advantages in the market.”
Dr. Pen is a graduate of the University of Groningen where he earned a master’s degree in chemistry and Ph.D. in biochemistry. Prior to founding JP Bioconsult, he held various research and commercial roles in Mogen International N.V., a plant biotechnology company that used genetic engineering to develop crops with improved characteristics, and in Zeneca and Syngenta when Mogen became part thereof.
Dr. Pen added, “It is an honor and a privilege to become part of Verdant Partners. It is my intention to fully utilize my technical and commercial skills, in conjunction with the expertise already available at Verdant, for the benefit of Verdant’s clients.”
Dr. Pen can be reached at: janpen@verdantpartners.com or +31 (6) 53 861 090
Comments